503555-96-2 Usage
Uses
Used in Organic Synthesis:
N-BOC-5-AMINO-2-CHLOROBENZOIC ACID is used as a key intermediate for the synthesis of various organic compounds and materials. Its unique structure and functional groups contribute to the formation of complex organic molecules, making it a valuable tool in the field of chemical research.
Used in Pharmaceutical Research and Development:
In the pharmaceutical industry, N-BOC-5-AMINO-2-CHLOROBENZOIC ACID is used as a building block for the synthesis of peptide-based drugs. The BOC protecting group allows for selective deprotection and coupling reactions, facilitating the assembly of peptide sequences with precise control over the molecular structure.
Used in Medicinal Chemistry:
N-BOC-5-AMINO-2-CHLOROBENZOIC ACID is utilized in medicinal chemistry for the development of pharmaceutical drugs. The presence of an amino group and a chlorine atom endows the compound with potential reactivity and functionalization capabilities, allowing for the design and synthesis of novel drug candidates with improved pharmacological properties.
Used in Chemical Research:
N-BOC-5-AMINO-2-CHLOROBENZOIC ACID serves as a valuable tool in chemical research, enabling the exploration of new reaction pathways and the discovery of innovative synthetic methods. Its unique properties and reactivity contribute to the advancement of chemical science and the development of new technologies in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 503555-96-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,5,5 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 503555-96:
(8*5)+(7*0)+(6*3)+(5*5)+(4*5)+(3*5)+(2*9)+(1*6)=142
142 % 10 = 2
So 503555-96-2 is a valid CAS Registry Number.
503555-96-2Relevant academic research and scientific papers
CHEMICAL COMPOUNDS
-
Page/Page column 54, (2008/06/13)
The invention relates to chemical compounds, or pharmaceutically acceptable salts thereof of the formula which possess CSF 1R kinase inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
